Market overview
The global ampoule market is worth USD 1.0 bn in 2026 and is forecast to reach USD 1.4 bn by 2036, growing at a 3.6% CAGR. China is the largest country market and Clear glass is the largest by material segment.
| Scope | Sealed glass ampoules that hold injectable drugs, vaccines and diagnostic liquids, in clear and amber borosilicate glass, with colour break and open-end types. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 980 mn |
| Value 2026 | USD 1.0 bn |
| Value 2036 | USD 1.4 bn |
| CAGR 2026-2036 | 3.6% |
| Volume 2026 | 14,388 million pieces |
| Volume 2036 | 18,552 million pieces |
| Average price 2026 | USD 0.07 per piece |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Ampoule market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 1.02 bn |
| 2027 | USD 1.05 bn |
| 2028 | USD 1.09 bn |
| 2029 | USD 1.13 bn |
| 2030 | USD 1.17 bn |
| 2031 | USD 1.21 bn |
| 2032 | USD 1.26 bn |
| 2033 | USD 1.30 bn |
| 2034 | USD 1.35 bn |
| 2035 | USD 1.40 bn |
| 2036 | USD 1.45 bn |
Ampoule market segmentation
By material
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Clear glass | 58.0% | 54.2% | USD 590 mn | 2.9% |
| Amber glass | 34.0% | 36.7% | USD 346 mn | 4.4% |
| Coated and specialty glass | 8.0% | 9.1% | USD 81 mn | 4.9% |
By capacity
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Up to 2 mL | 54.0% | 53.2% | USD 549 mn | 3.4% |
| 2 to 10 mL | 36.0% | 36.5% | USD 366 mn | 3.7% |
| Above 10 mL | 10.0% | 10.3% | USD 102 mn | 3.9% |
By end use
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Injectable drugs | 58.0% | 56.9% | USD 590 mn | 3.4% |
| Vaccines | 14.0% | 15.1% | USD 142 mn | 4.4% |
| Diagnostics and reagents | 16.0% | 16.5% | USD 163 mn | 3.9% |
| Cosmetics and others | 12.0% | 11.4% | USD 122 mn | 3.1% |
By glass type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Borosilicate Type one | 74.0% | 74.0% | USD 753 mn | 3.6% |
| Treated soda-lime Type two | 20.0% | 20.0% | USD 203 mn | 3.6% |
| Soda-lime Type three | 6.0% | 6.0% | USD 61 mn | 3.6% |
By buyer
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pharma manufacturers | 56.0% | 54.0% | USD 570 mn | 3.2% |
| Fill-finish contract makers | 24.0% | 26.0% | USD 244 mn | 4.4% |
| Cosmetic and laboratory users | 20.0% | 20.0% | USD 203 mn | 3.6% |
Top 25 countries for ampoule by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 77.0% of 2026 revenue and the 25 countries below together hold 94.7%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | China | USD 244 mn | 24.0% | USD 361 mn | 4.0% |
| 2 | India | USD 132 mn | 13.0% | USD 220 mn | 5.2% |
| 3 | Germany | USD 81 mn | 8.0% | USD 104 mn | 2.5% |
| 4 | United States | USD 81 mn | 8.0% | USD 107 mn | 2.8% |
| 5 | Japan | USD 51 mn | 5.0% | USD 64 mn | 2.3% |
| 6 | Italy | USD 51 mn | 5.0% | USD 67 mn | 2.7% |
| 7 | Brazil | USD 41 mn | 4.0% | USD 59 mn | 3.9% |
| 8 | France | USD 36 mn | 3.5% | USD 46 mn | 2.7% |
| 9 | Russia | USD 36 mn | 3.5% | USD 46 mn | 2.7% |
| 10 | Indonesia | USD 31 mn | 3.0% | USD 49 mn | 4.9% |
| 11 | Spain | USD 18 mn | 1.8% | USD 22 mn | 2.2% |
| 12 | Poland | USD 14 mn | 1.4% | USD 20 mn | 3.4% |
| 13 | Turkey | USD 14 mn | 1.4% | USD 22 mn | 4.5% |
| 14 | Mexico | USD 14 mn | 1.4% | USD 20 mn | 3.4% |
| 15 | South Korea | USD 14 mn | 1.4% | USD 18 mn | 2.2% |
| 16 | Canada | USD 13 mn | 1.2% | USD 16 mn | 2.2% |
| 17 | Egypt | USD 11 mn | 1.1% | USD 17 mn | 4.5% |
| 18 | Pakistan | USD 11 mn | 1.1% | USD 18 mn | 5.4% |
| 19 | Bangladesh | USD 11 mn | 1.1% | USD 18 mn | 5.4% |
| 20 | Vietnam | USD 11 mn | 1.1% | USD 18 mn | 5.4% |
| 21 | Thailand | USD 11 mn | 1.1% | USD 15 mn | 3.4% |
| 22 | Iran | USD 11 mn | 1.1% | USD 13 mn | 2.2% |
| 23 | Switzerland | USD 11 mn | 1.1% | USD 13 mn | 2.2% |
| 24 | Argentina | USD 8.9 mn | 0.9% | USD 11 mn | 2.1% |
| 25 | Netherlands | USD 8.9 mn | 0.9% | USD 11 mn | 2.1% |
| Rest of world | USD 54 mn | 5.3% | USD 73 mn | 3.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- SCHOTT
- Gerresheimer
- Nipro
- Stevanato Group
- DWK Life Sciences
- Nippon Electric Glass
Group 2: Regional and specialist players
- SGD Pharma
- Bormioli Pharma
- Linuo Group
- Chongqing Zhengchuan Pharmaceutical Packaging
- Borosil
Group 3: Emerging and niche players
- Shandong Pharmaceutical Glass
- Neubor Glass
- Four Stars Glass
- Aijiren Technology
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the ampoule market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 3.6% is calculated from the resulting values.
The market is divided by material, by capacity, by end use, by glass type, by buyer. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the ampoule market?
The global ampoule market is estimated at USD 980 mn in 2025 and USD 1.0 bn in 2026.
How fast will the ampoule market grow?
It is forecast to reach USD 1.4 bn by 2036, a compound annual growth rate of 3.6% from 2026, an increase of USD 432 mn.
Which country is the largest market for ampoule?
China is the largest market by revenue at USD 244 mn in 2026, 24.0% of the global total. The three largest countries together hold 45.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 5.2% a year from 2026 to 2036.
Which ampoule segment is largest?
In the by material split, Clear glass is the largest segment with 58.0% of 2026 revenue.
Who are the leading ampoule companies?
Global leaders include SCHOTT, Gerresheimer, Nipro, Stevanato Group.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Hospital Capacity Management SolutionsUSD 1.0 bn · 11.0% CAGR
- Endoscopic Imaging Logistics And ServiceUSD 1.0 bn · 5.5% CAGR
- Oncology Biomarker Translation ServicesUSD 990 mn · 9.5% CAGR
- Comparator SourcingUSD 976 mn · 8.5% CAGR
- Endoluminal & Bronchoscopy RobotsUSD 976 mn · 17.0% CAGR
- Urology Ablation DevicesUSD 1.1 bn · 10.0% CAGR
- Multi-Organ Transplant MonitoringUSD 1.1 bn · 9.0% CAGR
- Digital Twins TechnologiesUSD 967 mn · 21.0% CAGR
← Amniotic Membrane Amyotrophic Lateral Sclerosis Gene Testing →